ALLIANCEBERNSTEIN L.P. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$6,477,011
+29.0%
199,3540.0%0.00%0.0%
Q1 2024$5,021,727
-36.8%
199,354
-18.5%
0.00%
-33.3%
Q4 2023$7,941,198
+63.6%
244,495
+37.3%
0.00%
+50.0%
Q3 2023$4,853,016
+16.5%
178,125
-4.9%
0.00%0.0%
Q2 2023$4,165,734
+0.5%
187,224
-2.2%
0.00%0.0%
Q1 2023$4,146,244
-0.7%
191,424
-6.9%
0.00%0.0%
Q4 2022$4,175,005
-20.7%
205,564
+0.1%
0.00%
-33.3%
Q3 2022$5,267,000
+7.9%
205,408
+0.0%
0.00%
+50.0%
Q2 2022$4,883,000
+3.3%
205,329
-2.2%
0.00%0.0%
Q1 2022$4,728,000
+1.6%
209,955
-10.6%
0.00%0.0%
Q4 2021$4,652,000
-31.4%
234,941
-31.9%
0.00%
-33.3%
Q3 2021$6,786,000
+27.9%
344,804
+43.0%
0.00%
+50.0%
Q2 2021$5,306,000
-9.9%
241,194
-2.6%
0.00%
-33.3%
Q1 2021$5,889,000
-8.5%
247,534
+0.6%
0.00%0.0%
Q4 2020$6,439,000
+50.3%
246,1340.0%0.00%
+50.0%
Q3 2020$4,284,000
-6.7%
246,134
-9.9%
0.00%
-33.3%
Q2 2020$4,593,000
+42.0%
273,040
+0.4%
0.00%
+50.0%
Q1 2020$3,234,000
-1.0%
272,020
+0.7%
0.00%0.0%
Q4 2019$3,268,000
-16.7%
270,070
-2.7%
0.00%0.0%
Q3 2019$3,924,000
+16.6%
277,620
-8.0%
0.00%0.0%
Q2 2019$3,365,000
+10.5%
301,770
+16.4%
0.00%0.0%
Q1 2019$3,044,000
-12.1%
259,2700.0%0.00%
-33.3%
Q4 2018$3,464,000
-4.7%
259,2700.0%0.00%
+50.0%
Q3 2018$3,635,000
-54.6%
259,270
-49.1%
0.00%
-66.7%
Q2 2018$8,006,000
+118.7%
509,270
+128.9%
0.01%
+100.0%
Q1 2018$3,660,000
-18.2%
222,510
-10.2%
0.00%0.0%
Q4 2017$4,473,000
-11.0%
247,690
-4.9%
0.00%
-25.0%
Q3 2017$5,025,000
+42.6%
260,360
-12.8%
0.00%
+33.3%
Q2 2017$3,523,000
-7.8%
298,540
-14.4%
0.00%0.0%
Q1 2017$3,822,000
+30.7%
348,680
-13.5%
0.00%
+50.0%
Q4 2016$2,925,000
+12.4%
402,940
+0.7%
0.00%0.0%
Q3 2016$2,602,000
+113.5%
400,240
+79.2%
0.00%
+100.0%
Q2 2016$1,219,000
+251.3%
223,320
+201.0%
0.00%
Q1 2016$347,000
-6.2%
74,2000.0%0.00%
Q4 2015$370,000
+28.5%
74,200
-3.3%
0.00%
Q3 2015$288,000
-38.7%
76,700
-1.9%
0.00%
Q2 2015$470,000
+20.2%
78,200
+12.0%
0.00%
Q1 2015$391,000
+88.9%
69,800
+1.0%
0.00%
Q4 2014$207,000
+11.9%
69,1000.0%0.00%
Q3 2014$185,000
-4.1%
69,1000.0%0.00%
Q2 2014$193,000
-43.1%
69,100
-11.1%
0.00%
Q1 2014$339,000
+29.4%
77,700
-4.7%
0.00%
Q4 2013$262,000
+56.9%
81,500
-22.3%
0.00%
Q3 2013$167,000
-10.7%
104,900
-3.0%
0.00%
Q2 2013$187,000108,1070.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,303,147$209,1569.24%
TANAKA CAPITAL MANAGEMENT INC 90,876$2,2895.64%
Checkpoint Capital L.P. 273,776$6,896,4174.61%
Novo Holdings A/S 2,411,362$60,742,2094.19%
Ikarian Capital, LLC 994,500$25,051,4552.75%
Parallel Advisors, LLC 3,815,677$96,116,9042.60%
Quantedge Capital Pte Ltd 180,642$4,550,3721.91%
Kynam Capital Management, LP 585,900$14,758,8211.54%
S&T BANK/PA 290,487$7,3171.40%
AlphaCentric Advisors LLC 85,000$2,141,1501.29%
View complete list of CORCEPT THERAPEUTICS INC shareholders